Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Proline rich nuclear receptor coactivator 2 pseudogene 1 (PNRC2P1) is a non-protein-coding pseudogene derived from the functional PNRC2 gene. Pseudogenes such as PNRC2P1 are characterized by DNA sequence homology to their parent gene, but they are unable to be translated into functional proteins due to disabling mutations or lack of regulatory elements[1][3]. Most pseudogenes are biological "junk DNA," though occasionally, transcripts from pseudogenes can play regulatory roles. No specific biological function, disease association, or therapeutic relevance has been described for PNRC2P1[1][3]. This entity should not be considered a conventional drug target or functional molecule.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Proline rich nuclear receptor coactivator 2 pseudogene 1 (PNRC2P1).